Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

National Cancer Institute Best Case Series program.

Zia FZ, White JD.

Integr Cancer Ther. 2009 Jun;8(2):113-4. No abstract available.

PMID:
19691176
3.

The National Cancer Institute best case series program: a summary of cases of cancer patients treated with unconventional therapies in India.

Olaku O, Zia F, Santana JM, White JD.

Integr Cancer Ther. 2013 Sep;12(5):385-92. doi: 10.1177/1534735412473641. Epub 2013 Jan 25.

PMID:
23355475
4.

Physician Data Query (PDQ(R)) update.

[No authors listed]

J Natl Cancer Inst. 2012 May 2;104(9):655-6. doi: 10.1093/jnci/djs231. Epub 2012 Apr 18. No abstract available.

PMID:
22517987
5.

Review of the best case series methodology: best case series results of East-West Cancer Center.

Yoo HS, Cho CK, Hong MS.

Integr Cancer Ther. 2008 Sep;7(3):182-8. doi: 10.1177/1534735408322844.

PMID:
18815149
6.

Alternative therapies getting notice through Best Case Series Program.

Vanchieri C.

J Natl Cancer Inst. 2000 Oct 4;92(19):1558-60. No abstract available.

PMID:
11018087
7.

National Cancer Institute's support of research to further integrative oncology practice.

White JD.

J Natl Cancer Inst Monogr. 2014 Nov;2014(50):286-7. doi: 10.1093/jncimonographs/lgu036. No abstract available.

8.

Cancer complementary and alternative medicine research at the US National Cancer Institute.

Jia L.

Chin J Integr Med. 2012 May;18(5):325-32. doi: 10.1007/s11655-011-0950-5. Epub 2012 Jan 12.

PMID:
22241505
9.

Cancer Research and the OCCAM.

Smith W.

Explore (NY). 2007 Jul-Aug;3(4):396-403. No abstract available.

PMID:
17681261
10.

Imaging as a biomarker for therapy response: cancer as a prototype for the creation of research resources.

McLennan G, Clarke L, Hohl RJ.

Clin Pharmacol Ther. 2008 Oct;84(4):433-6. doi: 10.1038/clpt.2008.171. No abstract available.

PMID:
18802422
11.

National Cancer Institute-sponsored cooperative groups: changing process to speed progress.

Montello M, Mooney M, Denicoff A, Adler J, Goldberg J, Abrams J.

Clin Lymphoma Myeloma. 2009 Jun;9(3):194-6. doi: 10.3816/CLM.2009.n.040. No abstract available.

PMID:
19525187
12.
13.
14.
15.

[Major institutions for complementary and alternative medicine in the United States: National Cancer Institute and Harvard Medical School].

Fu JY.

Zhong Xi Yi Jie He Xue Bao. 2008 Sep;6(9):987-9. doi: 10.3736/jcim20080924. Chinese. No abstract available.

16.

Where did the scientific method go?

Noseda M, McLean GR.

Nat Biotechnol. 2008 Jan;26(1):28-9. doi: 10.1038/nbt0108-28. No abstract available.

PMID:
18183010
17.

Response to Where did the scientific method go?

[No authors listed]

Nat Biotechnol. 2008 Jan;26(1):29. doi: 10.1038/nbt0108-29a. No abstract available.

PMID:
18183012
18.

Cancer: a roadmap for the land of small tumors.

Jensen RT.

Nat Rev Endocrinol. 2011 Jun;7(6):319-21. doi: 10.1038/nrendo.2011.73. Epub 2011 Apr 26. No abstract available.

PMID:
21556022
19.

Cancer clinical trials--a chronic but curable crisis.

Young RC.

N Engl J Med. 2010 Jul 22;363(4):306-9. doi: 10.1056/NEJMp1005843. Epub 2010 Jun 16. No abstract available.

PMID:
20554976
20.

Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer.

Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD.

ACS Nano. 2010 Feb 23;4(2):589-94. doi: 10.1021/nn100073g.

PMID:
20175564

Supplemental Content

Support Center